Public Relations
Find in here all AESGP public relations releases, including news about position papers, statements and joint statements.
Want more? Do not hesitate to check also our Resources and News pages!
Positions
Health Union
Pharma Law
Pharma Strategy
Position paper
Reply on the Evaluation and Revision of Pharma Law
Digital
eHealth
Position paper
Position on Paving the way for the digitalisation of the self-care sector
Health Union
Position paper
Reply to European Commission’s Inception Impact Assessment on a European Health Emergency Preparedness and Response Authority (HERA)
EMA
Health Union
Position paper
Position on a reinforced EMA mandate (European Health Union)
Health Data
Position paper
Reply to European Commission’s Roadmap on Health Data Space
Environment
Pharma Strategy
Position paper
Reply to European Commission’s Roadmap for the Pharmaceutical Strategy
Position paper
Self-care
Shortages
Position Paper on Shortages of medicinal products for citizens in Europe
Medical Devices
Position paper
Position Paper on Rule 21 of the MDR
Environment
OTC
Position paper
Press release
Self-care
Position Paper on Antimicrobial Resistance
Brexit
EMA
Medical Devices
OTC
Position paper
Self-care
Position on the implications of the UK exit from the European Union
Statements
Cancer
Self-care
Statement
Reaction to European Beating Cancer Plan
OTC
Self-care
Statement
Reaction to European Commission’s Communication on the EU Pharmaceutical Strategy
Press release
Shortages
Reaction to European Parliament Report on shortages of medicines
COVID-19
Self-care
Shortages
Statement
Remarks on EU4Health Programme
OTC
Self-care
Statement
Reaction to European Commission’s Roadmap on the Pharmaceutical Strategy
Food supplements
OTC
Self-care
Statement
Reaction to European Commission’s Farm to Fork Strategy release
COVID-19
Response to EPF's Open Memo to the Health Industry
COVID-19
OTC
Press release
Self-care
WHO confirms no scientific evidence linking ibuprofen and the worsening of COVID-19
COVID-19
EMA
OTC
Press release
Self-care
No link between the use of ibuprofen and worsening of COVID-19
Food supplements
OTC
Press release
Self-care
Reply to European Commission’s Roadmap on Beating Cancer Plan
Joint Statements
Health Data
Statement
European Stakeholder Group Statement - Maintaining the exchange of critical health data
ePI
Position paper
AESGP, EFPIA and Medicines for Europe reflections on EMA – HMA – EC Key principles for electronic product information
Letter
Medical Devices
Joint Industry Letter on EU Standardisation Policy
Environment
Press release
Statement
European Pharmaceutical Industry Statement on the Update on the Progress and Implementation of the EU Strategic Approach to Pharmaceuticals in the Environment
Brexit
Statement
Joint EU-UK pharmaceutical industry response to Specialised Committee outcome
Statement
EU Health Coalition: 10 recommendations to build a stronger EU Health Union
Environment
Statement
EU Pharma Industry's joint statement on the European Parliament’s Resolution on Pharmaceuticals in the Environment
Brexit
Statement
Joint Letter on the Need for a Mutual Recognition Agreement between the EU and UK
COVID-19
European Industry trade and supply chain needs to respond to Covid-19
COVID-19
Statement